Neotonus Frequently Asked Questions (FAQ)
When was Neotonus founded?
Neotonus was founded in 1997.
Where is Neotonus's headquarters?
Neotonus's headquarters is located at 30 South Park Square, Marietta.
What is Neotonus's latest funding round?
Neotonus's latest funding round is Unattributed - IV.
How much did Neotonus raise?
Neotonus raised a total of $15.25M.
Who are the investors of Neotonus?
Investors of Neotonus include Noro-Moseley Partners, Antares Capital Corporation, Wakefield Group, Crown Advisors and AdventHealth.
Who are Neotonus's competitors?
Competitors of Neotonus include OrthAlign, Freedom Innovations, Uromedica, Solace Therapeutics, Stanmore Implants and 7 more.
Compare Neotonus to Competitors
Freedom Innovations is a high technology provider of premium prosthetic devices, a growing segment of the non-invasive orthopedic market. It deals with making prosthetic devices with latest technological developments and customization for lower limb amputations. The branded carbon fiber foot products lead the industry in reputation and growth rate. The company's first microprocessor-controlled product, the Pli' MPC Knee, was introduced in May 2007, serving as an entry into the SMART technology arena.What aims to make the company and the products is the high customization in the prosthetic devices market ranging from different limbs for swimmers to bikers to soldiers and so on. In February 2012, Health Evolution Partners acquired a majority stake in Freedom Innovations. The valuation of Freedom Innovations was undisclosed. Other terms of the deal were not released.
NanoPowers aims to develop artificial muscles for various implant indications. The Company has developed several animal proof of concepts, and is entering preclinical stages with devices aimed for the treatment of urinary and fecal incontinences.
Varix Medical Corporation, located in Sunnyvale, Calif., is a medical device company focused on developing products for the minimally invasive treatment of chronic venous insufficiency, commonly referred to as "varicose veins." For patients with advanced stages of varicose veins, laser- and RF-based (radiofrequency) treatments have been developed, but each device has deficiencies making them less-than-optimal solutions. Varix Medical's platform technology will enable physicians to efficiently and effectively treat more types of diseased veins than is currently possible when using either laser or RF devices. Additional treatable vessels include tortuous sub-truncal vessels and other visible smaller varicose veins. The Varix platform employs a vapor-based endovenous ablation system that will consist of a disposable catheter, a catheter introducer or delivery system, and a reusable vapor generator. RCT and Coronis Medical Ventures LLC., formed Varix in August 2007 and acquired the technology under license from Tsunami MedTech LLC. Coronis and RCT have been the primary in investors in Varix.
Conformis is a medical technology company focused on advancing orthopedic patient care and creating a world without joint pain. The company offers personalized solutions through its image-to-implant platinum services program as well as data-informed, standardized solutions. It was founded in 2004 and is based in Billerica, Massachusetts.
S.A.M.O. S.p.A. specializes in innovative solutions for orthopedic surgery within the medical devices industry. The company designs, manufactures, and markets a range of orthopedic prostheses, including hip and knee replacements, to meet the needs of surgeons worldwide. These products are aimed at improving patient outcomes in joint replacement surgeries. It was founded in 1939 and is based in Italy.
EastMed is a Halifax based company incorporated to develop, manufacture and market medical devices. It is currently developing a new self-fitting incontinence pessary for women. Per the company, a Canadian Patent has been secured and a US patent is pending.